|1.||Roberts, L Jackson: 4 articles (01/2012 - 09/2002)|
|2.||Mori, Trevor A: 3 articles (06/2014 - 11/2011)|
|3.||Buonocore, Giuseppe: 2 articles (09/2012 - 03/2009)|
|4.||Phillips, Michael: 2 articles (01/2012 - 11/2011)|
|5.||Corcoran, Tomas B: 2 articles (01/2012 - 11/2011)|
|6.||Barden, Anne E: 2 articles (01/2012 - 11/2011)|
|7.||Galano, Jean-Marie: 2 articles (01/2012 - 11/2011)|
|8.||Durand, Thierry: 2 articles (01/2012 - 11/2011)|
|9.||Mas, Emilie: 2 articles (01/2012 - 11/2011)|
|10.||Signorini, Cinzia: 2 articles (07/2011 - 03/2009)|
|1.||Alzheimer Disease (Alzheimer's Disease)
09/24/2002 - "The formation of neuroprostanes, isoprostane-like compounds formed from oxidation of docosahexaenoic acid, which is uniquely enriched in the brain, is increased in Alzheimer's disease. "
01/01/2001 - "Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease."
01/01/2001 - "Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease."
|2.||Brain Injuries (Brain Injury)
09/01/2012 - "Neuroprostanes and neurofurans are derived from the peroxidation of docosahexanoic acid, which is abundant in neurons and could therefore more selectively represent oxidative brain injury. "
11/15/2011 - "Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury?"
06/01/2014 - "Levels of F₂-isoprostanes and F₄-neuroprostanes were low and variable in zebrafish brains such that statistically significant changes due to hypoxia or chemical mimicry of hypoxia could not be observed. "
09/01/2012 - "Hypoxia and reoxygenation significantly increased the levels of isoprostanes, isofurans, neuroprostanes, and neurofurans in the cerebral cortex. "
|4.||Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
08/01/2011 - "The rise in plasma hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, and allantoin was highest 6 to 12 hours after stroke onset, whereas plasma urate was significantly lower than controls on Days 1 to 3. After adjusting for age and baseline National Institutes of Health Stroke Scale, baseline plasma esterified hydroxyeicosatetraenoic acid products (OR, 1.01; 95% CI, 1.01 to 1.02), plasma urate (1.01; 1.00 to 1.01), and plasma free F₄-neuroprostanes (2.73; 1.76 to 3.93) were associated with 90-day good functional recovery (modified Rankin Scale ≤1). "
08/01/2011 - "Serial blood and urine samples of ischemic stroke subjects and age-matched control subjects were assayed for F₂-isoprostanes, hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, 24-hydroxycholesterol, allantoin, and urate. "
|2.||F2-Isoprostanes (F2 Isoprostanes)
|3.||Biological Markers (Surrogate Marker)
|4.||Uric Acid (Urate)